semaglutide clinical trial Live Updates on Semaglutide's Current and Future Uses SELECT Trial
Description
Ozempic is in the class of drugs glucagon-like peptide-1 receptor agonists, but it selectively agonizes GLP-1 receptors
A 2024 study from Beth Israel Deaconess Medical Center found that about 15 million Americans use the new generation of weight-loss drugs, known as GLP-1 agonists, which require a once-weekly injection
Gastroenterology 137 (3), 9971005 (2009)
Most users find that symptoms become predictable within a few weeks
Contact us today to discuss how we can support your dental health during your GLP-1 treatment journey
PlexusDx patients typically titrate every 4 weeksmoving from 0.25mg to 0.5mg to 1mg to 2.4mgallowing your body to adapt while building momentum
